Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Cir Cir ; 91(5): 709-712, 2023.
Article in English | MEDLINE | ID: mdl-37844898

ABSTRACT

Eosinophilic enteritis (EE) is characterized by intense eosinophilic infiltrate of the gastrointestinal tract. Clinical manifestations depend on the affected segment and intestinal layer. First-line treatment is systemic corticosteroids; surgery is reserved for complications. 84-year-old male patient with a history of right hemicolectomy and two episodes of intestinal obstruction presented to the ED with abdominal pain, distension, nausea, and vomiting. CBC showed leukocytosis and no eosinophilia. Contrast-enhanced CT revealed stenosis with thickening of the distal intestinal wall and partial intestinal obstruction. Colonoscopy found aphthous ulcers. Histopathology reported EE. The patient received budesonide and metronidazole, with resolution within 24 h.


La enteritis eosinofílica (EE) se caracteriza por infiltrado eosinofilico del tracto GI. Las manifestaciones clínicas dependen de la capa intestinal afectada. Se recomiendan esteroides sistémicos como primera línea de tratamiento, reservando la cirugía para complicaciones. Masculino de 84 años con antecedente de hemicolectomía derecha y dos episodios de oclusión intestinal acude al servicio de urgencias con dolor abdominal, distensión, náusea y vómito. Laboratorio reportó leucocitosis, sin eosinofilia. Tomografía con contraste evidenció estenosis, con engrosamiento de la pared del intestino delgado e imagen compatible con oclusión intestinal. La colonoscopía demostró ulceras en íleon terminal la cual reporto EE. Se inició tratamiento con budesonide y metronidazol, con adecuada respuesta y resolución a las 24 h.


Subject(s)
Enteritis , Eosinophilia , Gastritis , Intestinal Obstruction , Male , Humans , Aged, 80 and over , Enteritis/complications , Enteritis/diagnosis , Gastritis/complications , Gastritis/diagnosis , Eosinophilia/complications , Eosinophilia/diagnosis , Intestinal Obstruction/etiology , Intestinal Obstruction/surgery , Intestinal Obstruction/pathology
2.
Cir Cir ; 84(1): 65-8, 2016.
Article in Spanish | MEDLINE | ID: mdl-26242822

ABSTRACT

BACKGROUND: Acute pseudo-obstruction of the colon is a disorder characterised by an increase in intra-luminal pressure that leads to ischaemia and necrosis of the intestinal wall. The mechanism that produces the lesion is unknown, although it has been associated with: trauma, anaesthesia, or drugs that alter the autonomic nervous system. The pathophysiology of medication induced colon toxicity can progress to a perforated colon and potentially death. OBJECTIVE: Present a case of a colonic pseudo-obstruction in a patient with polypharmacy as the only risk factor and to review the medical literature related to the treatment of this pathology. CLINICAL CASE: The case is presented of a 67 year old woman with colonic pseudo-obstruction who presented with diffuse abdominal pain and distension. The pain progressed and reached an intensity of 8/10, and was accompanied by fever and tachycardia. There was evidence of free intraperitoneal air in the radiological studies. The only risk factor was the use of multiple drugs. The colonic pseudo-obstruction progressed to intestinal perforation, requiring surgical treatment, which resolved the problem successfully. CONCLUSION: It is important to consider drug interaction in patients with multiple diseases, as it may develop complications that can be avoided if detected on time.


Subject(s)
Abdomen, Acute/etiology , Colonic Pseudo-Obstruction/chemically induced , Gastrointestinal Motility/drug effects , Intestinal Perforation/etiology , Aged , Anastomosis, Surgical/methods , Antihypertensive Agents/adverse effects , Antihypertensive Agents/therapeutic use , Atorvastatin/adverse effects , Atorvastatin/therapeutic use , Cholinergic Antagonists/adverse effects , Cholinergic Antagonists/pharmacology , Cholinergic Antagonists/therapeutic use , Colon/surgery , Colon, Sigmoid/surgery , Colonic Pseudo-Obstruction/physiopathology , Colonic Pseudo-Obstruction/surgery , Drug Synergism , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Ileum/surgery , Intestinal Perforation/surgery , Ketoconazole/therapeutic use , Levetiracetam , Meropenem , Nifedipine/adverse effects , Nifedipine/pharmacology , Nifedipine/therapeutic use , Peritonitis/drug therapy , Peritonitis/etiology , Piracetam/adverse effects , Piracetam/analogs & derivatives , Piracetam/therapeutic use , Polypharmacy , Quetiapine Fumarate/adverse effects , Quetiapine Fumarate/therapeutic use , Raloxifene Hydrochloride/adverse effects , Raloxifene Hydrochloride/therapeutic use , Respiration, Artificial , Risk Factors , Thienamycins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...